Lung Cancer (Treatment)

Cancer Treatment Identifies Optimal Survival Rates

Published in Cancer Weekly, September 16th, 1996

In an encouraging breakthrough for lung cancer treatment, Dr. Robert Dillman, Hoag Cancer Center, Newport Beach, California, has led a seven-year study that supports the usage of a treatment option that dramatically boosts survival rates for many patients.

The study, featured in the September 4, 1996, edition of the Journal of the National Cancer Institute (JNCI), is receiving widespread national recognition. Dillman's trial, which involved patients with local and regionally advanced non-small-cell lung cancer, shows the benefits of treating the disease with chemotherapy followed by radiation therapy, as opposed to radiation therapy alone.

According...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1996-09-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry